vs
Acadia Healthcare Company, Inc.(ACHC)与Maplebear Inc.(CART)财务数据对比。点击上方公司名可切换其他公司
Maplebear Inc.的季度营收约是Acadia Healthcare Company, Inc.的1.2倍($992.0M vs $829.0M),Maplebear Inc.净利率更高(8.2% vs 0.5%,领先7.6%),Maplebear Inc.同比增速更快(12.3% vs 7.5%),过去两年Maplebear Inc.的营收复合增速更高(10.0% vs 2.0%)
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商,目前在美国及波多黎各地区运营着超过225家医疗机构,搭建了覆盖广泛的行为健康服务网络,为有相关需求的人群提供专业的心理健康与行为干预服务。
Maplebear Inc. 以Instacart为品牌开展业务,是总部位于美国旧金山的零售媒体及配送企业,在美国和加拿大运营生鲜杂货配送与自提服务。用户可通过官网及移动应用从合作商户订购食品杂货,在法律允许的地区还可选购酒类商品,所有订单由专属采购专员负责拣选、打包并配送上门。
ACHC vs CART — 直观对比
营收规模更大
CART
是对方的1.2倍
$829.0M
营收增速更快
CART
高出4.8%
7.5%
净利率更高
CART
高出7.6%
0.5%
两年增速更快
CART
近两年复合增速
2.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $829.0M | $992.0M |
| 净利润 | $4.5M | $81.0M |
| 毛利率 | — | 72.3% |
| 营业利润率 | — | 9.9% |
| 净利率 | 0.5% | 8.2% |
| 营收同比 | 7.5% | 12.3% |
| 净利润同比 | -50.8% | -45.3% |
| 每股收益(稀释后) | $0.05 | $0.31 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ACHC
CART
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $992.0M | ||
| Q3 25 | $851.6M | $939.0M | ||
| Q2 25 | $869.2M | $914.0M | ||
| Q1 25 | $770.5M | $897.0M | ||
| Q4 24 | $774.2M | $883.0M | ||
| Q3 24 | $815.6M | $852.0M | ||
| Q2 24 | $796.0M | $823.0M |
净利润
ACHC
CART
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $81.0M | ||
| Q3 25 | $36.2M | $144.0M | ||
| Q2 25 | $30.1M | $116.0M | ||
| Q1 25 | $8.4M | $106.0M | ||
| Q4 24 | $32.6M | $148.0M | ||
| Q3 24 | $68.1M | $118.0M | ||
| Q2 24 | $78.5M | $61.0M |
毛利率
ACHC
CART
| Q1 26 | — | — | ||
| Q4 25 | — | 72.3% | ||
| Q3 25 | — | 73.7% | ||
| Q2 25 | — | 74.2% | ||
| Q1 25 | — | 74.8% | ||
| Q4 24 | — | 75.2% | ||
| Q3 24 | — | 75.2% | ||
| Q2 24 | — | 75.7% |
营业利润率
ACHC
CART
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 9.9% | ||
| Q3 25 | 4.7% | 17.7% | ||
| Q2 25 | 5.8% | 13.6% | ||
| Q1 25 | 1.7% | 12.3% | ||
| Q4 24 | 4.9% | 17.6% | ||
| Q3 24 | 12.1% | 16.2% | ||
| Q2 24 | 13.4% | 6.3% |
净利率
ACHC
CART
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 8.2% | ||
| Q3 25 | 4.3% | 15.3% | ||
| Q2 25 | 3.5% | 12.7% | ||
| Q1 25 | 1.1% | 11.8% | ||
| Q4 24 | 4.2% | 16.8% | ||
| Q3 24 | 8.4% | 13.8% | ||
| Q2 24 | 9.9% | 7.4% |
每股收益(稀释后)
ACHC
CART
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $0.31 | ||
| Q3 25 | $0.40 | $0.51 | ||
| Q2 25 | $0.33 | $0.41 | ||
| Q1 25 | $0.09 | $0.37 | ||
| Q4 24 | $0.36 | $0.53 | ||
| Q3 24 | $0.74 | $0.42 | ||
| Q2 24 | $0.85 | $0.20 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $158.5M | $687.0M |
| 总债务越低越好 | $2.5B | — |
| 股东权益账面价值 | $2.0B | $2.5B |
| 总资产 | $5.5B | $3.7B |
| 负债/权益比越低杠杆越低 | 1.29× | — |
8季度趋势,按日历期对齐
现金及短期投资
ACHC
CART
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $687.0M | ||
| Q3 25 | $118.7M | $1.7B | ||
| Q2 25 | $131.4M | $1.6B | ||
| Q1 25 | $91.2M | $1.6B | ||
| Q4 24 | $76.3M | $1.4B | ||
| Q3 24 | $82.1M | $1.3B | ||
| Q2 24 | $77.2M | $1.4B |
总债务
ACHC
CART
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — |
股东权益
ACHC
CART
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $2.5B | ||
| Q3 25 | $3.1B | $3.5B | ||
| Q2 25 | $3.1B | $3.3B | ||
| Q1 25 | $3.0B | $3.2B | ||
| Q4 24 | $3.1B | $3.1B | ||
| Q3 24 | $3.0B | $2.9B | ||
| Q2 24 | $3.0B | $3.0B |
总资产
ACHC
CART
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $3.7B | ||
| Q3 25 | $6.4B | $4.5B | ||
| Q2 25 | $6.3B | $4.4B | ||
| Q1 25 | $6.1B | $4.3B | ||
| Q4 24 | $6.0B | $4.1B | ||
| Q3 24 | $5.9B | $3.9B | ||
| Q2 24 | $5.7B | $4.0B |
负债/权益比
ACHC
CART
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $61.5M | $183.0M |
| 自由现金流经营现金流 - 资本支出 | — | $171.0M |
| 自由现金流率自由现金流/营收 | — | 17.2% |
| 资本支出强度资本支出/营收 | — | 1.2% |
| 现金转化率经营现金流/净利润 | 13.78× | 2.26× |
| 过去12个月自由现金流最近4个季度 | — | $910.0M |
8季度趋势,按日历期对齐
经营现金流
ACHC
CART
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $183.0M | ||
| Q3 25 | $73.2M | $287.0M | ||
| Q2 25 | $133.5M | $203.0M | ||
| Q1 25 | $11.5M | $298.0M | ||
| Q4 24 | $116.7M | $153.0M | ||
| Q3 24 | $163.1M | $185.0M | ||
| Q2 24 | $171.1M | $244.0M |
自由现金流
ACHC
CART
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $171.0M | ||
| Q3 25 | $-63.0M | $272.0M | ||
| Q2 25 | $-34.2M | $187.0M | ||
| Q1 25 | $-163.2M | $280.0M | ||
| Q4 24 | $-86.8M | $141.0M | ||
| Q3 24 | $-27.1M | $171.0M | ||
| Q2 24 | $16.9M | $220.0M |
自由现金流率
ACHC
CART
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 17.2% | ||
| Q3 25 | -7.4% | 29.0% | ||
| Q2 25 | -3.9% | 20.5% | ||
| Q1 25 | -21.2% | 31.2% | ||
| Q4 24 | -11.2% | 16.0% | ||
| Q3 24 | -3.3% | 20.1% | ||
| Q2 24 | 2.1% | 26.7% |
资本支出强度
ACHC
CART
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 1.2% | ||
| Q3 25 | 16.0% | 1.6% | ||
| Q2 25 | 19.3% | 1.8% | ||
| Q1 25 | 22.7% | 2.0% | ||
| Q4 24 | 26.3% | 1.4% | ||
| Q3 24 | 23.3% | 1.6% | ||
| Q2 24 | 19.4% | 2.9% |
现金转化率
ACHC
CART
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 2.26× | ||
| Q3 25 | 2.02× | 1.99× | ||
| Q2 25 | 4.43× | 1.75× | ||
| Q1 25 | 1.37× | 2.81× | ||
| Q4 24 | 3.58× | 1.03× | ||
| Q3 24 | 2.39× | 1.57× | ||
| Q2 24 | 2.18× | 4.00× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
CART
| Transaction | $698.0M | 70% |
| Advertising And Other | $294.0M | 30% |